Dyne Therapeutics Newsroom

Dyne Therapeutics Analyst Ratings

BenzingaNov 26 18:03

RBC Capital Initiates Dyne Therapeutics(DYN.US) With Buy Rating, Announces Target Price $45

Futu NewsNov 26 09:31

Dyne Therapeutics Is Maintained at Buy by Chardan Capital

Dow JonesNov 14 07:44

Morgan Stanley Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $52

Futu NewsNov 13 21:33

Oppenheimer Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $55

Futu NewsNov 13 21:33

Oppenheimer Sticks to Their Buy Rating for Dyne Therapeutics (DYN)

TipRanksNov 13 21:10

H.C. Wainwright Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $55

Futu NewsNov 13 20:33

Dyne Therapeutics Receives Buy Rating Following IND Clearance and Promising Trial Updates

TipRanksNov 13 18:42

Morgan Stanley Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $52

Futu NewsNov 13 18:38

Dyne Therapeutics Analyst Ratings

BenzingaOct 24 19:10

J.P. Morgan Downgrades Dyne Therapeutics(DYN.US) to Hold Rating, Cuts Target Price to $35

Futu NewsOct 24 06:31

Morgan Stanley Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $52

Futu NewsOct 10 18:31

Analysts' Top Healthcare Picks: 10x Genomics (TXG), Dyne Therapeutics (DYN)

TipRanksOct 10 17:42

Dyne Therapeutics Analyst Ratings

BenzingaSep 23 20:37

Piper Sandler Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $53

Futu NewsSep 23 19:32

Piper Sandler Sticks to Its Buy Rating for Dyne Therapeutics (DYN)

TipRanksSep 23 18:48

H.C. Wainwright Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $55

Futu NewsSep 5 19:35

A Quick Look at Today's Ratings for Dyne Therapeutics(DYN.US), With a Forecast Between $50 to $55

Futu NewsSep 4 21:00

Dyne Therapeutics Analyst Ratings

BenzingaSep 4 13:01

Buy Rating Affirmed Amidst Dose Adjustments and Promising Trial Results for Dyne Therapeutics

TipRanksSep 4 10:38